2014 Quality Performance Results Table:

Measure Number Measure Number
ACO Performance Rate Mean performance rate (SSP- ACOs)
ACO-1 Getting Timely Care, Appointments, and Information  84.32 80.13
ACO-2 How Well Your Doctors Communicate  93.78 92.39
ACO-3 Patients’ Rating of Doctor  93.73 91.58
ACO-4 Access to Specialists  82.47 83.97
ACO-5 Health Promotion and Education 54.85 58.29
ACO-6 Shared Decision Making  76.74 74.6
ACO-7 Health Status/Functional Status  71.79 71.1
ACO-8 Risk Standardized, All Condition Readmissions  14.89 15.15
ACO-9 ASC Admissions: COPD or Asthma in Older Adults 1.83 1.08
ACO-10 ASC Admission: HF 1.32 1.19
ACO-11 Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment 61.59 76.71
ACO-12 Medication Reconciliation  96.26 82.61
ACO-13 Falls: Screening for Fall Risk  47.20 45.6
ACO-14 Influenza Immunization 31.63 57.51
ACO-15 Pneumococcal Vaccination 47.45 55.03
ACO-16 Adult Weight Screening and Follow-up 40.88 66.75
ACO-17 Tobacco Use Assessment and Cessation Intervention 67.40 86.79
ACO-18 Depression Screening 4.68 39.27
ACO-19 Colorectal Cancer Screening 10.22 56.14
ACO-20 Mammography Screening 19.71 61.41
ACO-21 Proportion of Adults who had blood pressure screened in past 2 years 25.00 60.24
ACO-22 Hemoglobin A1c Control (HbA1c) (  67.49 N/A
ACO-23 Low Density Lipoprotein (LDL) (< 100 mg/dL) N/A N/A
ACO-24 Blood Pressure (BP) < 140/90  62.32 N/A
ACO-25 Tobacco Non-Use  73.40 N/A
ACO-26 Aspirin Use  72.16 N/A
ACO-27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 24.57 20.35
ACO-28 Percent of beneficiaries with hypertension whose BP < 140/90 61.80 68.02
ACO-29 Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl N/A N/A
ACO-30 Percent of beneficiaries who use Aspirin or other antithrombotic 79.26 80.79
ACO-31 Beta-Blocker Therapy for LVSD 88.89 82.71
ACO-32 Drug Therapy for Lowering LDL-Cholesterol N/A N/A
ACO-33 (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) 67.90 N/A